导师风采
王朝东
浏览量:138   转发量:3

个人信息

Personal Information

  • 教授
  • 导师类别:硕士,博士生导师
  • 性别: 男
  • 学历:博士研究生
  • 学位:博士

联系方式

Contact Information

  • 所属院系:附属北京朝阳医院
  • 所属专业: 神经病学
  • 邮箱 : cdongwang01@126.com
  • 工作电话 : 010-52012035

个人简介

Personal Profile

教授、主任医师、博士研究生导师,现任首都医科大学附属北京朝阳医院神经内科主任。曾任首都医科大学宣武医院神经内科遗传代谢专业主任、神经生物学研究室主任、国家老年疾病临床医学研究中心办公室主任。兼任国家重点研发计划项目“主动健康与老龄化科技应对”重点项目专家组成员、中华医学会神经病学分会神经遗传学组委员、中国医师协会医学遗传医师分会神经遗传病学组委员、中国遗传学会遗传诊断分会委员,中国卒中学会遗传学分会副主任委员、中国妇幼保健协会儿童药食同源干预委员会常务委员、北京市医学会遗传学分会常务委员。长期从事神经遗传代谢病和帕金森病、肌萎缩侧索硬化症(“渐冻症”)的临床诊疗及分子机制研究。探索出一套独特的"五步法"分子会诊系统,用于神经遗传代谢病的基因数据解读和分子诊断。已开设“神经遗传代谢病分子会诊门诊”7年余,并在全国多地举办过20多期“临基医疗”遗传代谢病数据解读沙龙。发现并从功能上阐明了PCDHA9是“渐冻症”的一个新致病基因,这也是我国学者在该领域独立发现的第一个基因。主持国家科技部重点研发计划项目子课题1项、国家自然科学基金面上项目6项、省局级课题6项,横向研究项目5项。在国内外专业杂志发表论文100余篇,其中在Nature Communications, Brain,Alzheimer’s & Dementia, Autophagy, npj Parkinson’s diseases, Oncogene, Cellular and Molecular Immunology, Communications Biology等SCI收录杂志90余篇。获中华医学科技二等奖、中国医院科技创新奖三等奖、北京市科学技术一等奖、江西省科技进步三等奖各一项,获得国家发明专利1项,软件著作权6项。主编《神经遗传代谢病例表型分析和分子解读-成人篇》及《儿童篇》(科学文献技术出版社)、《新编神经酸与脑健康》(清华大学出版社), 参编《遗传咨询》等书籍3本。


  • 研究方向Research Directions
帕金森病及神经遗传代谢疾病的分子机制与精准诊疗,神经退行性疾病的分子标志物发现
2. 机电结构优化与控制 研究内容:在对机电结构进行分析和优化的基础上,运用控制理论进行结构参数的调整,使结构性能满足设计要求。1. 仿生结构材料拓扑优化设计, 仿生机械设计 研究内容:以仿生结构为研究对象,运用连续体结构拓扑优化设计理论和方法,对多相仿生结构(机构)材料进行2. 机电结构优化与控制 研究内容:在对机电结构进行分析和优化的基础上,运用控制理论进行结构参数的调整,使结构性能满足设计要求。1. 仿生结构材料拓扑优化设计, 仿生机械设计 研究内容:以仿生结构为研究对象,运用连续体结构拓扑优化设计理论和方法,对多相仿生结构(机构)材料进行整体布局设计。 整体布局设计。
团队展示


项目情况


科研项目

1、ACO2调控帕金森病线粒体和自噬功能异常的新机制研究。国家自然科学基金面上项目(No. 82371259),49万元,2024- 2027,负责人。

2、PCDHA9基因突变介导的肌萎缩侧索硬化症分子机制研究。国家自然科学基金面上项目(No. 82171412),55万元,2022-2025,负责人。

3、乌头酸酶ACO2调控LRRK2介导的帕金森病机制研究。国家自然科学基金面上项目(No. 81771212),54万元,2018-2021,负责人。

4、帕金森病的发病机制与危险因素研究。国家重点研发计划项目(2016YFC1306000),国家科技部,220万元,2016.7-2020.12,子课题负责人。

5、老年神经疾病新致病基因的发现和机制研究。国家科技部临床医学研究中心后补助项目,150万元,2023-2025,负责人。

6、免疫相关GTP酶-1介导的自噬调节在多发性硬化发病机制中的作用。国家自然科学基金面上项目(No. 81371320),70万元,2014-2017,负责人。

7、帕金森病分子分型和早期预测模式的初步建立和随访验证。国家自然科学基金面上项目(No. 81271249),16万元,2012-2013,负责人。

8、LRG-47在多发性硬化小鼠模型发病机制中的关键作用研究。国家自然基金面上项目(No. 30870885),30万元,2009-2011,负责人。

9、老年(脊柱外科)患者围术期综合管理方案和创新技术研究。北京市属医学科学院所公益发展改革试点项目(首医研No.2019-2),2020-2022,子课题负责人。

10、神经系统慢性疾病易感、致病基因突变及代谢组筛查方法体系建立。合作课题(202103-202312), 60.00万元, 负责人。

11、眼动技术在神经遗传和退行性疾病早期预警和辅助中的应用研究方案,合作课题(2023.4-2025.4),50.00万元,负责人。

12、慢性肾病透析治疗的神经系统并发症发生机制及关键诊疗技术研究,合作课题(2024.1-2026.12),50.00万元,负责人。


研究成果-获得奖励

科技奖励:

1. 高龄外科围手术期关键技术创新体系的建设,2021年度中国医院科技创新奖三等奖

2. 帕金森病及运动障碍性疾病的分子诊断和功能影像研究,2016年度中华医学科技奖二等奖

3.  帕金森病的发病机制、预警和干预研究,2015年度北京市科学技术奖一等奖

4. 多发性硬化的临床和遗传学研究与应用,2011年度江西省科技进步三等奖

5. 免疫相关GTP酶家族成员IRGM1在多发性硬化及脑血管疾病中的多重调节机制,2014年度福建三明市科技进步一等奖


研究成果-近5年发表的主要论文

1. Zhong J*, Wang C*,#, Zhang D*, Yao X*, Zhao Q, Huang X, Lin F, Xue C, Wang Y, He R, Li XY, Li Q, Wang M, Zhao S, Afridi SK, Zhou W, Wang Z, Xu Y#, & Xu Z#. PCDHA9 as a candidate gene for amyotrophic lateral sclerosis. Nature Communications, 2024 Mar 11;15(1):2189. *Co-first; #Co-corresponding author.

2. Li Y*, Ying Y*, Yao T*, Jia X, Liang H, Tang W, Jia X, Song H, Shao X, Wang DJJ, Wang C#, Cheng X#, Yang Q#. Decreased water exchange rate across blood-brain barrier in hereditary cerebral small vessel disease. Brain. 2023: 146; 3079–3087. #Co-corresponding author.

3. Ying Y, Li Y, Yao T, Shao X, Tang W, Montagne A, Chabriat H, Wang DJJ, Wang C#, Yang Q#, Cheng X#. Heterogeneous blood-brain barrier dysfunction in cerebral small vessel diseases. Alzheimer's & Dementia, 2024, Jul; 20(7): 4527-4539. #Co-corresponding author.

4. Zhu J, Xu F, Lai H, Yuan H, Li XY, Hu J, Li W, Liu L# & Wang C#. ACO2 deficiency increases vulnerability to Parkinson’s disease via dysregulating mitochondrial function and histone acetylation-mediated transcription of autophagy genes. Communications Biology. 2023 Nov 25;6(1):1201. (https://doi.org/10.1038/s42003-023-05570-y; www. nature. Com /commsbio).

5. Wang C*, Liu H*, Li XY, Ma J, Gu Z, Feng X, Xie S, Tang B, Chen S, Wang W, Wang J, Zhang J, Chan P. High-depth whole-genome sequencing identifies structure variants, copy number variants and short tandem repeats associated with Parkinson’s disease. npj Parkinson’s Disease, 2024, July 23, 10:134:1-14.

6. Jiao J, Gao G, Zhu J, Wang C#, Liu L#, Yang H#. Binding of α-synuclein to ACO2 promotes progressive mitochondrial dysfunction in Parkinson's disease models. Redox Biol. 2024 Oct 17; 77:103399. doi: 10.1016/j.redox.2024.103399. #Co-corresponding author.

7. Zhu J, Yao T, Wang C#. Mitochondrial and autophagic dysfunctions of skin fibroblasts derived from pantothenate kinase-associated neurodegeneration patients carrying PANK2 mutations and the rescuing effects of allantoin. Parkinsonism and Related Disorders, 2025, 134:107806.

8. Li XY, Lai H, Li X, Xu F, Song Y, Wang Z, Li Q, Lin R, Xu Z#, Wang C#. Genetic profiles of multiple system atrophy revealed by exome sequencing, long-read sequencing and SCA repeat expansion analysis. European Journal of Neurology, 2024, Aug 17: e16441. doi: 10.1111/ene.16441.

9. Shen J, Sun X, Chu Y, Kong C, Wang C#. Relationship between the use of high-risk perioperative medications and postoperative cardiac complications in older adults undergoing spinal surgery: A retrospective cohort study. Maturitas. 2025 Apr 4; 197:108255.

10. Li XY, Wang Z, Yang Y, Lin R, Wang C#. Domain-specific phenotypes in LINS1 -related disorder—a Chinese family with the Q92X variant and literature review. American Journal of Medical Genetics Part C, 2024; e3208:1-10.

11. Dong Y, Jia M, Tan S, Li XY, Song Y, Wang X, Wang Z, Wang C#. Clinical, genetic, and neuroimaging profiles of autosomal recessive spinocerebellar ataxia type 4 caused by novel VPS13D variants in Chinese. American Journal of Medical Genetics Part A, 2024, 2024 Jul 26:e63828. doi: 10.1002/ajmg.a.63828.

12. Li X*, Lai H*, Wang P, Feng S, Feng X, Kong C, Wu, Yin C, Shen J, Yan S, Han R, Liu J, Ren X, Li Y, Huang H, Li X, Zhang Y, Lu S, Wang T, Zhao G, Wang C#, the APPLE-MDT Research Team, Xuanwu Hospital, National Clinical Research Center for Geriatric Diseases. Risk factors for postoperative cognitive decline after orthopedic surgery in elderly Chinese patients: a retrospective cohort study. Clinical Interventions in Aging, 2024:19 491–502.

13. Li XY, Teng X, Lai H, Dai J, Peng F, Xu F, Zhu J, Li X, Hu J, Li W, He R, Chen L, Chen Y, Ding C, Zhao G, Chen X#, Ye Q#, Xu Z# and Wang C#. Pyruvate is modified by tea/coffee metabolites and reversely correlated with multiple system atrophy and Parkinson's disease. Heliyon, 2024;10(5): e26588. #Co-corresponding author.

14. He R*, Zeng Y*, Wang C*, Chen L, Cai G, Chen Y, Wang Y, Ye Q and Chen X. Associative Role of HLA-DRB1 as a Protective Factor for Susceptibility and Progression of Parkinson's Disease: A Chinese Cross-Sectional and Longitudinal Study. Frontiers in Aging Neuroscience, section Parkinson’s Disease and Aging-related Movement Disorders, Published 22 February 2024, https://doi.org/10.3389/fnagi.2024.1361492. *Co-first author.

15. Shen J, Yan S, Chhetri JK, Chu Y, Wang P, Feng S, Wang T, Wang C*, Zhao G. A Relationship between perioperative medication and prolonged postoperative hospital stay in older adults with spinal surgery: a retrospective cohort study. Canadian Geriatrics Journal, 2024, Dec 1;27(4):500-518. *Corresponding author.

16. Lai H, Li XY, Xu F, Zhu J, Li X, Song Y, Wang X, Wang Z, Wang C#. Applications of Machine Learning to Diagnosis of Parkinson's Disease. Brain Sci. 2023 Nov 3;13(11):1546.

17. Zhang L*, Li XY*, Xu F*, Gao L, Wang Z, Wang X, Li X, Liu M, Zhu J, Yao T, Ye J, Qi XH, Wang Y, Zhao G#, Wang C#; Xuanwu Molecular Counselling Group for Neurogenetic Diseases. Multidisciplinary molecular consultation increases the diagnosis of pediatric epileptic encephalopathy and neurodevelopmental disorders. Mol Genet Genomic Med. 2023 Jul 24; e2243. #Co-corresponding author.

18. Si L, Wang Z, Li XY, Song Y, Yao T, Xu E, Wang X, Wang C#. Novel mutations and molecular pathways identified in patients with brain iron accumulation disorders. Neurogenetics, 2023, Jul 15. doi: 10.1007/s10048-023-00725-9.

19. Li W, Luo J, Peng F, Liu R, Bai X, Wang T, Zhang X, Zhu J, Li XY, Wang Z, Liu W, Wang J, Zhang L, Chen X, Xue T, Ding C, Wang C#, Jiao L#. Metabolomics identifies lipid profiles of human carotid atherosclerosis. Atherosclerosis. 2023 Jan; 364:20-28. #Co-corresponding author.

20. Yao T, Zhu J, Wu X, Li X, Fu Y, Wang Y, Wang Z, Xu F, Lai H, He A, Teng L#, Wang C#, Song H#. Heterozygous HTRA1 Mutations Cause Cerebral Small Vessel Diseases: Genetic, Clinical, and Pathologic Findings From 3 Chinese Pedigrees. Neurol Genet, 2022 Dec 5;8(6):e200044. #Co-corresponding author.

21. Xu F, Huang S, Li XY, Lin J, Feng X, Xie S, Wang Z, Li X, Zhu J, Lai H, Xu Y, Huang X, Yao X# and Wang C#. Identification of TARDBP Gly298Ser as a founder mutation for amyotrophic lateral sclerosis in Southern China. BMC Medical Genomics, 2022, 15:173.

22. Lai H, Li XY, Hu J, Li W, Xu F, Zhu J, He R, Weng H, Chen L, Yu J, Li X, Song Y, Wang X, Wang Z, Li W, Kang R, Li Y, Xu J, Deng Y#, Ye Q#, Wang C#. Development and validation of a predictive nomogram for possible REM sleep behavior disorders. Frontiers in Neurology, 2022 Jun 29;13:903721. #Co-corresponding author.

23. Yao T, Qiao H, Sun J, Li X, Song Y, Xu F, Gao L, Zhang D, Yan Z, Ye C, Lai H, Liang Z*, Wu T#, Wang C#. Clinical and preclinical neuroimaging changes in spinocerebellar ataxia type 12-a study of three Chinese pedigrees. European Neurology, 2022, Jul 19:1-11. #Co-corresponding author.

24. Li W, Hu J, Li X, Lu Z, Li X, Wang C# and Yu S#. Receptor-Dependent Endocytosis Mediates a-Synuclein Oligomer Transport Into Red Blood Cells. Frontiers in Aging Neuroscience. 2022 May 20;14:899892. #Co-Corresponding author.

25. Zhu J, Xu F, Wang C#, Li XY, Zhao G#. A novel loss-of-function compound heterozygous mutation of MYORG causes idiopathic basal ganglia calcification 7. Parkinsonism Relat Disord. 2022 Mar 21;97:65-67. #Co-Corresponding author.

26. Ma R, Ye J, Han J, Gao L#, Wang C#, Wang Y#. Case Report: A Novel Missense Mutation c.517G>C in the UMPS Gene Associated With Mild Orotic Aciduria. Front Neurol. 2022 Mar 9;13:819116. #Co-Corresponding author.

27. Li W, Wang T, Zhang X, Zhu J, Li XY, Peng F, Dai J, Wang J,Zhang L, Wang Y, Chen X, Xue T, Ding C#, Wang C#, Jiao L#. Distinct lipid profiles of radiation-induced carotid plaques from atherosclerotic carotid plaques revealed by UPLC-QTOF-MS and DESI-MSI. Radiotherapy and Oncology. 2022 Feb;167:25-33. #Co-Corresponding author.

28. Ma R, Duan Y, Zhang L, Qi X, Zhang L, Pan S, Gao L#, Wang C#, Wang Y#.  SCN1A-Related Epilepsy: Novel Mutations and Rare Phenotypes. Front Mol Neurosci. 2022 May 19 ;15:826183. #Co-Corresponding author.

29. Wang X, Li XY, Piao Y, Yuan G, Lin Y, Chen H, Wang Z, Li C, Wang C*. Hartnup disease presenting as hereditary spastic paraplegia and severe peripheral neuropathy. Am J Med Genet A. 2022 Jan;188(1):237-242. *Corresponding author. 

30. Li W, Hu J, Li X, Lu Z, Li X, Wang C#, Yu S#. Receptor-Dependent Endocytosis Mediates α-Synuclein Oligomer Transport Into Red Blood Cells. Front Aging Neurosci. 2022 May 20;14:899892. #Co-Corresponding author.

31. Dong Y, Li XY, Wanga XL, Xu F, Wang ZJ, Song Y, Li Q, Lin R, Wang C#. Genetic, clinical and neuroimaging profiles of sporadic and autosomal recessive hereditary spastic paraplegia cases in Chinese. Neuroscience Letters, 2021, Jul 10;761:136108.

32. Wang Z, Wu H,Piao Y,Wang C#. Cervical cord hemorrhage in cerebral cavernous malformations. Journal of Clinical Neurology, 2021;17:576-578.

33. Wang Z, Song Y, Wang X, Li X, Xu F, Si L, Dong Y, Yao T, Zhu J, Lai H, Li W, Lin F, Huang H, Wang C#. Autosomal recessive spastic ataxia of Charlevoix-Saguenay caused by novel mutations in SACS gene: A report of two Chinese families. Neuroscience Letters. 2021;752:135831.

34. Wang Z, Song Y, Zhu W, Wang X, Li X, Xu F, Si L, Yao T, Zhu J, Lai H, Li W, Lin F, Wang C#. A novel FBXO7-R345P mutation in a Chinese family with autosomal recessive parkinsonian-pyramidal syndrome. Parkinsonism and Related Disorders, 2021, 88:62–67. *Corresponding author.

35. Liu L, Cui B, Chu M, Cui Y, Jing DL, Li D, Xie K, Kong Y, Xia T, Wang C#, Wu L#. The frequency of genetic mutations associated with behavioral 2 variant frontotemporal dementia in Chinese Han patients. Frontiers in Aging Neuroscience, 2021, Jul 8;13:699836. #Co-Corresponding author.

36. Li XY, Li W, Li X, Li XR, Sun L, Yang W, Cai Y, Chen Z, Wu J, Wang C# and Yu S#. Alterations of Erythrocytic Phosphorylated Alpha-Synuclein in Different Subtypes and Stages of Parkinson’s Disease. Frontiers in Aging Neuroscience. 2021, Sep 29;13:623977. doi: 10.3389/fnagi.2021.623977. #Co-corresponding author.

37. Pan S, Li X, Li L, Lin H, Wang D, Zhang X, Zhao X, Ye J, Huang Z, Lin Y, Duan Y, Ma R, Gao L#, Wang C#, Wang Y#. Comprehensive genetic, clinical and electrophysiological studies of familial cortical myoclonic tremor with epilepsy 1 highlight the role of gene configurations. Seizure. 2021 Feb 23;87:69-74. doi: 10.1016 /j. Seizure. 2021.02.026. #Co-corresponding author.

38. Li Y, Sun B, Wang Z, He Z, Yang F, Wang H, Fang C, Chen Z, Ling L, Wang C#, Huang X#. Mutation screening of the GLE1 gene in a large Chinese cohort of amyotrophic lateral sclerosis patients. Frontiers in Neuroscience, section Neurogenomics. 2021;15:595775. #Co-corresponding author.

39. Li XY, Yang W, Li X, Li XR, Li W, Song Q, Sun L, Lin F, Chen Z, Wang C#, Yu S#. Phosphorylated alpha-synuclein in red blood cells as a potential diagnostic biomarker for multiple system atrophy: A pilot study. Parkinson’s Disease 2020; 8740419. #Co-corresponding author. 


研究成果-发明专利及软件著作权

发明专利:

1、帕金森病代谢组学标志物及其应用。发明人:王朝东,李旭颖,李娴。发明专利,专利号:ZL 2022 1 0274266.X。

2、神经疾病辅助诊疗决策系统(IOS版)v1.0。著作权人:王朝东。证书号:软著登字第2417426号。

3、神经专科体检辅助系统。著作权人:王朝东。证书号:软著登字第2055493号

4、神经科专家助手(NeuroAid)平台。著作权人:王朝东。证书号:软著登字第2707111号。

5. 帕金森病精准表型采集分析系统 v2.0。著作权人:王朝东。证书号:软著登字第2021SR0493259号。

6. 运动神经元病的表型采集分析系统 v1.0。著作权人:王朝东。证书号:软著登字第2021SR0433137号。

7. 癫痫的表型采集分析系统 v1.0。著作权人:王朝东。证书号:软著登字第2021SR0433140号。


学生信息
学术型硕士
专业学位硕士
专业学位博士
学生信息
当前位置:教师主页 > 学生信息
入学日期
所学专业
学号
学位
招生信息
当前位置:教师主页 > 招生信息
招生学院
招生专业
研究方向
招生人数
推免人数
考试方式
招生类别
招生年份

首都医科大学研究生院招生办公室

360eol提供技术支持

Copyright © 2011 -All Rights Reserved 苏ICP备08015343号-4

文件上传中...

分享
回到
首页
回到
顶部